DASI Simulations

DASI Simulations is a private, commercial-stage company founded in 2020 and headquartered in Boston, MA. It has developed an FDA-cleared AI platform that generates patient-specific cardiac simulations to predict complications like coronary obstruction and leaflet thrombosis prior to TAVR procedures. The company has established significant commercial partnerships with industry leaders like Medtronic and the Cleveland Clinic, indicating early market validation and a services-based business model focused on selling simulations to hospitals and health systems. DASI operates at the intersection of AI, computational modeling, and interventional cardiology, targeting a large and growing structural heart disease market.

AI-powered computational modeling platform that creates patient-specific digital heart simulations from medical imaging (e.g., CT scans) to predict procedural complications like leaflet thrombosis and coronary obstruction for structural heart interventions.

DASI operates in the emerging digital surgery planning space. Potential competitors include large medical imaging companies (e.g., GE, Siemens) integrating AI into their visualization suites, other AI-focused startups in cardiovascular planning, and possibly the in-house development efforts of major device companies. DASI's early FDA clearance, strong academic validation, and exclusive partnership with Medtronic provide a significant competitive moat in the TAVR segment.